Real-world efficacy and safety of dupilumab for atopic dermatitis in a Hispanic population: A single-center retrospective cohort study

被引:0
作者
Santiago-Vazquez, Marely [1 ]
Pelet, Natalia [2 ]
Cuesta, Jose M. [3 ]
Michelen, Eduardo [2 ]
Ramos, Alvaro J. [1 ]
Martin, Rafael F. [1 ]
机构
[1] Univ Puerto Rico, Dept Dermatol, San Juan, PR USA
[2] Univ Puerto Rico, Transit Year Program, San Juan, PR USA
[3] VA Caribbean Healthcare Syst, San Juan, PR USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
34201
引用
收藏
页码:AB199 / AB199
页数:1
相关论文
共 50 条
[41]   Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China [J].
Deng, Sisi ;
Wang, Huan ;
Chen, Qiquan ;
Chen, Xueqin ;
Song, Xiao ;
Chen, Shuguang ;
Kong, Minmin ;
Song, Zhiqiang .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
[42]   Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study [J].
Nachshon, Liat ;
Goldberg, Michael R. ;
Levy, Michael B. ;
Appel, Michael Y. ;
Epstein-Rigbi, Naama ;
Lidholm, Jonas ;
Holmqvist, Marie ;
Katz, Yitzhak ;
Elizur, Arnon .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (08) :2775-+
[43]   Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study [J].
Dhar, Sandipan ;
De, Abhishek ;
Srinivas, Sahana M. .
INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) :297-301
[44]   Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study [J].
Georgakopoulos, Jorge R. ;
Sheka, Dropen ;
Rankin, Brian ;
Maliyar, Khalad ;
Rimke, Alexander ;
Prajapati, Vimal H. ;
Yeung, Jensen .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) :1308-1311
[45]   Real-world effectiveness and safety of baricitinib including its effect on biomarkers and laboratory data in Japanese adult patients with atopic dermatitis: a single-center retrospective study [J].
Watanabe, Ayu ;
Kamata, Masahiro ;
Okada, Yoshiki ;
Suzuki, Shoya ;
Ito, Makoto ;
Mizukawa, Itsumi ;
Uchida, Hideaki ;
Egawa, Shota ;
Chijiwa, Chika ;
Hiura, Azusa ;
Fukaya, Saki ;
Hayashi, Kotaro ;
Fukuyasu, Atsuko ;
Tanaka, Takamitsu ;
Ishikawa, Takeko ;
Tada, Yayoi .
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2024, 7
[46]   Real-world response to dupilumab in patients with atopic dermatitis: a retrospective review of 100 patients [J].
Bajwa, D. ;
Worthy, O. ;
Griffiths, S. ;
Hussain, A. ;
Ball, S. ;
Meggitt, S. ;
Reynolds, N. ;
Hampton, P. .
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 :64-64
[47]   Comments on "Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: A real-world cohort analysis" [J].
Li, Rong ;
Zhang, Junyan ;
Wang, Lei ;
Zhang, Li-yun .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 93 (01) :e39-e40
[48]   Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study [J].
Levine, Jasmine ;
Islam, Rahib K. ;
Mo, Lillian ;
Kim, Brian S. ;
Talia, Jordan ;
Lipner, Shari R. ;
Ungar, Benjamin .
ALLERGY, 2025,
[49]   Success, Safety, and Efficacy of the Mynx Femoral Closure Device in a Real-World Cohort: Single-Center Experience [J].
Hutchings, David ;
Hayat, Afzal ;
Karunakaran, Arun ;
Malik, Nadim .
JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (03) :104-108
[50]   TREATGermany registry: "real-world effectiveness" of dupilumab in atopic dermatitis [J].
Weidinger, S. ;
Stoelzl, D. ;
Abraham, S. ;
Haufe, E. ;
Heratizadeh, A. ;
Werfel, T. ;
Schmitt, J. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) :S236-S236